Evaluating the risk–benefit ratio of adjuvant trastuzumab-based therapy for T1a,bN0M0 HER2-positive breast carcinomas
| Image |  |
|---|---|
| Description | scientific article published on June 23, 2011 |
| Author/s | |
| Publication date | June 23, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://academic.oup.com/annonc/article-pdf/22/11/2530/528340/mdr308.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |